Ubiquitin control of cytosolic DNA sets immune responses to DNA damage

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• DNA damage in tumor cells can trigger innate immune responses.
• Cytosolic DNA sensing via cyclic GMP-AMP synthase (cGAS) and STING pathway is crucial for anti-tumor immunity.
• Dysregulation of DNA clearance mechanisms can lead to aberrant immune activation.

Purpose of the Study:

• To investigate the mechanisms controlling cytosolic DNA clearance after DNA damage.
• To understand how cytosolic DNA clearance influences the cGAS-STING pathway activation.
• To explore the implications for radioimmunotherapy response.

Main Methods:

• Utilized molecular biology techniques to identify key proteins involved in DNA clearance.
• Investigated the interaction between SPOP, USP7, and TREX1 in response to DNA damage.
• Assessed the impact of this axis on cGAS-STING pathway activation and tumor cell response to radioimmunotherapy.

Main Results:

• Identified a novel axis involving SPOP, USP7, and TREX1 that regulates cytosolic DNA clearance.
• Demonstrated that this axis controls the activation of the cGAS-STING pathway.
• Showed that targeting USP7 and TREX1 can modulate the response to radioimmunotherapy.

Conclusions:

• The SPOP-USP7-TREX1 axis is a critical regulator of cytosolic DNA homeostasis and immune sensing.
• This pathway represents a potential therapeutic target to enhance anti-tumor immunity and radioimmunotherapy efficacy.
• Targeting USP7 and TREX1 may improve patient selection and combination strategies for cancer treatment.